Search research articles
Contact Us
Filters
Showing results (321-330 of 440) with videos related to
Page
of 44
Sort By:
Nature Communications
|
February 12, 2024
Author Correction: Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain
Carrie M Long, Paul A Beare, Diane Cockrell, et al.
Frontiers in Cellular and Infection Microbiology
|
February 19, 2015
Orientia tsutsugamushi ankyrin repeat-containing protein family members are Type 1 secretion system substrates that traffic to the host cell endoplasmic reticulum
Lauren VieBrock, Sean M Evans, Andrea R Beyer, et al.
Nature Communications
|
January 24, 2024
Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain
Carrie M Long, Paul A Beare, Diane Cockrell, et al.
Frontiers in Nutrition
|
September 25, 2023
Tannat grape pomace as an ingredient for potential functional biscuits: bioactive compound identification, <i>in vitro</i> bioactivity, food safety, and sensory evaluation
Victoria Olt, Jessica Báez, Romina Curbelo, et al.
Brain Research Bulletin
|
December 29, 2012
Anticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar rats
Cátia Dos Santos Branco, Gustavo Scola, Adriana Dalpicolli Rodrigues, et al.
Journal of Alzheimer'S Disease : JAD
|
January 12, 2010
Genome-wide scan of copy number variation in late-onset Alzheimer's disease
Erin L Heinzen, Anna C Need, Kathleen M Hayden, et al.
Brain : a Journal of Neurology
|
May 26, 2025
SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics
Dulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Future Oncology (London, England)
|
November 21, 2025
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer
Friederike C Althoff, Fabian Acker, Sebastian Koschade, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
SLC35A2 loss of function variants affect glycomic signatures, neuronal fate, and network dynamics
Dulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Neurology. Genetics
|
August 18, 2020
D-DEMØ, a distinct phenotype caused by <i>ATP1A3</i> mutations
Lyndsey Prange, Milton Pratt, Kristin Herman, et al.
Page
of 44
Search research articles
Search
Showing results (321-330 of 440) with videos related to
Sort By:
Page
of 44
Nature Communications
|
February 12, 2024
Author Correction: Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain
Carrie M Long, Paul A Beare, Diane Cockrell, et al.
Frontiers in Cellular and Infection Microbiology
|
February 19, 2015
Orientia tsutsugamushi ankyrin repeat-containing protein family members are Type 1 secretion system substrates that traffic to the host cell endoplasmic reticulum
Lauren VieBrock, Sean M Evans, Andrea R Beyer, et al.
Nature Communications
|
January 24, 2024
Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain
Carrie M Long, Paul A Beare, Diane Cockrell, et al.
Frontiers in Nutrition
|
September 25, 2023
Tannat grape pomace as an ingredient for potential functional biscuits: bioactive compound identification, <i>in vitro</i> bioactivity, food safety, and sensory evaluation
Victoria Olt, Jessica Báez, Romina Curbelo, et al.
Brain Research Bulletin
|
December 29, 2012
Anticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar rats
Cátia Dos Santos Branco, Gustavo Scola, Adriana Dalpicolli Rodrigues, et al.
Journal of Alzheimer'S Disease : JAD
|
January 12, 2010
Genome-wide scan of copy number variation in late-onset Alzheimer's disease
Erin L Heinzen, Anna C Need, Kathleen M Hayden, et al.
Brain : a Journal of Neurology
|
May 26, 2025
SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics
Dulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Future Oncology (London, England)
|
November 21, 2025
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer
Friederike C Althoff, Fabian Acker, Sebastian Koschade, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
SLC35A2 loss of function variants affect glycomic signatures, neuronal fate, and network dynamics
Dulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Neurology. Genetics
|
August 18, 2020
D-DEMØ, a distinct phenotype caused by <i>ATP1A3</i> mutations
Lyndsey Prange, Milton Pratt, Kristin Herman, et al.
Page
of 44